Ruiz Autumn J, Russell Stephen J
Department of Molecular Medicine, Mayo Clinic College of Medicine;
Department of Molecular Medicine, Mayo Clinic College of Medicine.
J Vis Exp. 2017 Feb 6(120):55033. doi: 10.3791/55033.
Cell-specific restriction of viral replication without concomitant attenuation can benefit vaccine development, gene therapy, oncolytic virotherapy, and understanding the biological properties of viruses. There are several mechanisms for regulating viral tropism, however they tend to be virus class specific and many result in virus attenuation. Additionally, many viruses, including picornaviruses, exhibit size constraints that do not allow for incorporation of large amounts of foreign genetic material required for some targeting methods. MicroRNAs are short, non-coding RNAs that regulate gene expression in eukaryotic cells by binding complementary target sequences in messenger RNAs, preventing their translation or accelerating their degradation. Different cells exhibit distinct microRNA signatures and many microRNAs serve as biomarkers. These differential expression patterns can be exploited for restricting gene expression in cells that express specific microRNAs while maintaining expression in cells that do not. In regards to regulating viral tropism, sequences complementary to specific microRNAs are incorporated into the viral genome, generally in the 3' non-coding regions, targeting them for destruction in the presence of the cognate microRNAs thus preventing viral gene expression and/or replication. MicroRNA-targeting is a technique that theoretically can be applied to all viral vectors without altering the potency of the virus in the absence of the corresponding microRNAs. Here we describe experimental methods associated with generating a microRNA-targeted picornavirus and evaluating the efficacy and specificity of that targeting in vitro. This protocol is designed for a rapidly replicating virus with a lytic replication cycle, however, modification of the time points analyzed and the specific virus titration readouts used will aid in the adaptation of this protocol to many different viruses.
在不伴随病毒减毒的情况下对病毒复制进行细胞特异性限制,有助于疫苗开发、基因治疗、溶瘤病毒疗法以及了解病毒的生物学特性。调节病毒嗜性有多种机制,然而这些机制往往具有病毒类别特异性,且许多机制会导致病毒减毒。此外,包括微小核糖核酸病毒在内的许多病毒存在大小限制,无法容纳某些靶向方法所需的大量外源遗传物质。微小RNA是短的非编码RNA,通过与信使RNA中的互补靶序列结合来调节真核细胞中的基因表达,阻止其翻译或加速其降解。不同细胞表现出不同的微小RNA特征,许多微小RNA可作为生物标志物。这些差异表达模式可用于在表达特定微小RNA的细胞中限制基因表达,同时在不表达的细胞中维持表达。在调节病毒嗜性方面,与特定微小RNA互补的序列通常被整合到病毒基因组的3'非编码区,在同源微小RNA存在的情况下将其靶向破坏,从而阻止病毒基因表达和/或复制。微小RNA靶向技术理论上可应用于所有病毒载体,且在没有相应微小RNA时不会改变病毒的效力。在此,我们描述了与生成微小RNA靶向的微小核糖核酸病毒以及在体外评估该靶向的效力和特异性相关的实验方法。本方案针对具有裂解复制周期的快速复制病毒设计,然而,对分析的时间点和所使用的特定病毒滴定读数进行修改,将有助于使本方案适用于许多不同的病毒。